Avian Influenza

Viral inactivation method being explored for development of bird flu vaccine

Published in Medical Letter on the CDC and FDA, December 25th, 2005

U.S. BioDefense, Inc. (UBDE) announced that it is working with the U.S. National Institutes of Health to commercially evaluate its Universal Viral Inactivation Method. The company is also seeking major commercial partners to utilize the inactivation method in developing a special vaccine to combat the bird flu and the potential occurrence of an influenza pandemic.

The evaluation method that may lead to exploring development of special vaccines using new techniques, which may be more effective against new strains of viruses. Current techniques are dependent upon developing vaccines from cultures of a weakened pathogen, which can still result in the development of...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA

Source: Medical Letter on the CDC and FDA (2005-12-25)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry